As is known to all, ER, PR positive and luminalA in breast cancer are characterized by low invasiveness, better differentiation, and slow disease progression (Han & Kang, 2010), related to the satisfactory treatment response and good clinical outcomes. Here, ESR1 is linked to breast carcinoma.